Lantheus Holdings, Inc. (LNTH), a radiopharmaceutical company, experienced a 9% drop in its stock price on Tuesday after announcing a deal to acquire Evergreen Theragnostics, Inc.
Currently, trading at $90.03, the stock is down $8.28, marking an 8.42 percent decline on the Nasdaq.
Lantheus opened today at $99.91 after closing the previous day at $98.31. During the trading session, the stock has fluctuated between $89.85 and $100.99. Over the past 52 weeks, the stock has ranged from $51.79 to $126.89.
The acquisition, structured as an all-cash transaction, includes an upfront payment of $250 million and up to $752.5 million in potential milestone payments. While this move could strategically enhance Lantheus' product portfolio, the financial implications of such a sizable deal appear to have raised concerns among investors.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.